EVLO — Evelo Biosciences, Inc.

EVLOEvelo Biosciences, Inc.

0.0001USD0.00%Mkt Cap: 1898 USDP/E: —Last update: 2026-05-22

Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a who…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap1.90K USD

Enterprise Value16.69M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-114.53M USD

Revenue/Share—

Last Price0.0001 USD

Fiscal Year EndDec 2022

MR QuarterSep 2023

Employees66

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.00

PEG—

EV/EBITDA-0.24

EV/Revenue—

P/S—

P/B-0.00

EPS (TTM)-3.91

EPS (Forward)-1.85

52W Range

0.00010% of range0.0020

52W High0.0020 USD

52W Low0.0001 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE2294.21%

ROA-177.72%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-101.23M USD

CapEx (TTM)622.00K USD

FCF Margin—

FCF Yield-2282046.79%

Net Debt16.69M USD

Net Debt/EBITDA-0.24

Balance Sheet

Debt/Equity-10.24

Current Ratio0.48

Quick Ratio0.43

Book Value/Sh-1.4170 USD

Cash/Share0.9120 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:20

Split DateJun 30, 2023

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.18.98M

Float18.90M

Insiders0.00%

Institutions0.00%

Short Interest

Short Ratio0.1d

Short % Float2.22%

Short % Out.1.04%

Shares Short196.99K

Short (prev mo.)156.44K

Technical

SMA 500.0002 (-41.9%)

SMA 2000.0003 (-69.2%)

Beta1.67

S&P 52W Chg28.31%

Avg Vol (30d)595

Avg Vol (10d)0

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—